Comparison
Compounded GLP-1s vs Brand-Name GLP-1s
Compounded GLP-1 medications have become a popular alternative to brand-name drugs like Wegovy and Zepbound, especially during shortages. But compounded drugs are not the same as FDA-approved brand-name products, and understanding the tradeoffs matters before you choose.
| Category | Compounded GLP-1s | Brand-Name GLP-1s | Winner |
|---|---|---|---|
| FDA approval status | Not FDA-approved (compounded) | Fully FDA-approved | Brand-Name GLP-1s |
| Monthly cost (cash pay) | $149-299/mo | $900-1,300/mo without insurance | Compounded GLP-1s |
| Quality consistency | Varies by pharmacy | Consistent manufacturing | Brand-Name GLP-1s |
| Insurance coverage | Rarely covered | Often covered | Brand-Name GLP-1s |
| Availability | Easier during shortages | Subject to shortages | Compounded GLP-1s |
| Safety monitoring | State pharmacy board oversight | Full FDA oversight | Brand-Name GLP-1s |
| Best for | Uninsured patients, shortage periods | Insured patients, long-term use | Tie |
Final verdict
Brand-name GLP-1s have full FDA approval, consistent manufacturing, and broader insurance coverage. Compounded versions are cheaper and easier to access during shortages, but come with less regulatory oversight and potential quality variability. If you can get brand-name through insurance, that is generally the safer path.